{"id":48910,"date":"2026-10-23T18:36:13","date_gmt":"2026-10-23T16:36:13","guid":{"rendered":"https:\/\/www.channelafrica.co.za\/channelafrica\/?post_type=news&#038;p=48910"},"modified":"2026-10-23T18:36:13","modified_gmt":"2026-10-23T16:36:13","slug":"personalised-skin-cancer-vaccine-cuts-recurrence-death-risk-by-42","status":"publish","type":"news","link":"https:\/\/www.channelafrica.co.za\/channelafrica\/news\/personalised-skin-cancer-vaccine-cuts-recurrence-death-risk-by-42\/","title":{"rendered":"Personalised skin cancer vaccine cuts recurrence, death risk by 42%"},"content":{"rendered":"<p>A custom-built skin cancer vaccine is showing major promise in clinical trials, cutting the risk of melanoma returning or proving fatal by 42% when used alongside standard immunotherapy. During the study, two-thirds of participating patients received the experimental shot, which was tailor-made using genetic material drawn directly from their own tumor cells.<\/p>\n<p>&nbsp;<\/p>\n<p>According to Melanoma Specialist Dr Pippa Corrie, the technology marks an exciting leap forward for targeted medicine, though its overall long-term impact remains under evaluation. She noted that while the personalized approach is a fabulous next step, the trial serves as an essential proof of principle to demonstrate just how much the vaccine is worth in real-world clinical treatment.<\/p>\n<p>&nbsp;<\/p>\n<p>By training a patient&#8217;s immune system to pinpoint and attack the specific mutations unique to their tumor, researchers hope this customized approach will mark a major turning point in how doctors treat advanced skin cancers.<\/p>\n<p>&nbsp;<\/p>\n<p>&#8211;ChannelAfrica&#8211;<\/p>\n","protected":false},"featured_media":48911,"template":"","meta":{"_acf_changed":false,"_members_access_role":[],"_members_access_error":"","_links_to":"","_links_to_target":""},"news-type":[26],"class_list":["post-48910","news","type-news","status-publish","has-post-thumbnail","hentry","news-type-general_news","entry"],"acf":{"short_description":"Clinical trial shows custom skin cancer vaccine significantly slashes relapse risks","published_date":"2026-10-23 16:48:19","news_description":"Clinical trial shows custom skin cancer vaccine significantly slashes relapse risks","form_embed":"","author":"","image_caption":""},"_links":{"self":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news\/48910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":2,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news\/48910\/revisions"}],"predecessor-version":[{"id":48913,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news\/48910\/revisions\/48913"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/media\/48911"}],"wp:attachment":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/media?parent=48910"}],"wp:term":[{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news-type?post=48910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}